ARCHIVES

ODAC Recommends Femara Campath For FDA Approval.

This article is from The Cancer Letter archive.

Vol. 27 No. 01 | January 5, 2001

Download PDF Visit The Full Archive

Related Articles

Hepatitis B Vaccine Almost Ready, Blumberg Tells Science Writers

April 10, 1981

Drasga, Einhorn Make Appeal For Single-Payer Healthcare

January 31, 2014

National Academies: Changes Required To Reduce Incidence Of Medical Errors, Report Finds

December 3, 1999

Obituary: Michael Potter, 89, NIH Researcher

June 26, 2013

In Brief: Three, Perhaps Four May Be Recommended To Carter; Hugh Creech To Retire July 1

April 1, 1977

Low-Dose Tamoxifen May Be Effective In Treating Breast Cancer, Study Finds

April 25, 2003